Biocon zooms on entering into partnership with Sandoz

19 Jan 2018 Evaluate

Biocon is currently trading at Rs. 567.40, up by 27.80 points or 5.15% from its previous closing of Rs. 539.60 on the BSE.

The scrip opened at Rs. 548.00 and has touched a high and low of Rs. 575.30 and Rs. 545.35 respectively. So far 659098 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 575.30 on 19-Jan-2018 and a 52 week low of Rs. 294.71 on 25-May-2017.

Last one week high and low of the scrip stood at Rs. 575.30 and Rs. 525.65 respectively. The current market cap of the company is Rs. 34137.00 crore.

The promoters holding in the company stood at 60.67%, while Institutions and Non-Institutions held 20.39% and 18.94% respectively.

Biocon has entered into partnership with Sandoz, a Novartis division and a global leader in biosimilars, to develop, manufacture and commercialize multiple biosimilars in immunology and oncology for patients worldwide.

Under the terms of the agreement, both companies will share responsibility for end-to-end development, manufacturing and global regulatory approvals for a number of products and will have a cost and profit share arrangement globally. Worldwide commercialization responsibilities will be divided and each company's strengths will be leveraged within specific geographies. Sandoz will lead commercialization in North America (US and Canada) and the EU (including European Free Trade Association (EFTA) and Balkan states), while Biocon will lead commercialization in Rest of the World (including India, Russia and Commonwealth of Independent States (CIS)).

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.


Biocon Share Price

290.75 1.20 (0.41%)
25-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.55
Dr. Reddys Lab 6217.15
Cipla 1405.40
Zydus Lifesciences 953.50
Lupin 1589.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.